6Kearney PM,Whelton L,Reynolds K,et al.Glorb burden of hypertension:analysis of wordwide data.Lancet 2005;365:217-223.
7Turner RC,Millns H,Neil HA,et al.Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus; United kingdom prospective diabetes study.BMJ 1998;316:823-828.
8Adler AI,Stratton IM,Neil HA,et al.Association of sistolic blood pressure with macrovascular and microvascular complication of type 2 diabetes (UKPDS:36):prospective observation study.Brit Med 2000;321:412-419.
9Heim A,Feihl F,Waeber B.Advance:a morbidity mortality study of diabetes and hypertension.Rev Med Suisse 2008;4:28-33.
10Whitlock G,Clark C,Sherliker P,et al.Blood cholesterol and vascular mortality by age,sex,and blood pressure:a meta-analysis of individual data from 61 prospective studies with 55000 vascular death.Lancet 2007;370:1829-1839.
5WHO. Enhanced global strategy for further reducing the dis- ease burden due to leprosy (Plan period 2011-2015) ER3. New Delhi. WHO Regional Office for South-East Asia, 2009.
6WHO. Informal consultation on innovative approaches to further reduce leprosy burden in counties ER3. New Delhi WHO Re- gional Office for South-East Asia, 2008.
8Costa MD,Terra Fde S,Costa RD,et al.Assessment of quality of life of patients with leprosy reactional states treated in a dermatology reference center[J].An Bras Dermatol, 2012,87 ( 1 ) : 26-35.
9Lustosa AA, Nogueira LT, Pedrosa JI, et al.The impact of leprosy on health-related quality of life[J].Rev Soc Bras Med Trop,2011,44(5) :621-626.
10An JG, Ma JH, Xiao SX,et al. Quality of life in pa- tients with lepromatous leprosy in China [J]. J Eur Acad Dermatol Venereol, 2010,24 (7) : 827-832.
